Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)

SHE:301033 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	124.31	74.02	57.45	26.68	44.96	10.35
Short-Term Investments	-	-	54.48	-	-	-
Trading Asset Securities	199.49	231.81	137.85	192.82	147.07	375.57
Cash & Short-Term Investments	323.8	305.83	249.78	219.5	192.02	385.92
Cash Growth	26.83%	22.44%	13.80%	14.31%	-50.24%	77.41%
Accounts Receivable	23.25	25.03	24.16	18.08	10.42	5.32
Other Receivables	1.58	1.44	1.19	1.29	1.33	1.59
Receivables	24.83	26.46	25.36	19.37	11.75	6.91
Inventory	47.69	37.06	34.28	26.2	29.41	21.18
Prepaid Expenses	-	0.48	-	0	0.37	0.02
Other Current Assets	11.89	5.35	2.99	4.64	4.7	3.12
Total Current Assets	408.21	375.19	312.41	269.71	238.25	417.14
Property, Plant & Equipment	309.72	299.38	309.45	319.15	319.82	231.46
Long-Term Investments	65.23	96.37	60.27	83.01	30.1	-
Other Intangible Assets	62.71	68.09	63.05	70.01	51.31	54.66
Long-Term Deferred Tax Assets	6.5	9.83	7.67	4.38	0.93	4.24
Long-Term Deferred Charges	38.38	33.92	34.12	26.61	34.56	27.16
Other Long-Term Assets	66.01	12.66	12.26	14.09	69.94	12.12
Total Assets	956.76	895.44	799.23	786.97	744.92	746.78

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	18.33	16.42	7.59	31.93	32.73	32.73
Accrued Expenses	7.18	26.65	22.16	18.85	16.91	14.65
Current Portion of Long-Term Debt	-	-	-	3.91	26.83	-
Current Portion of Leases	-	-	1.01	1.78	1.67	2.4
Current Income Taxes Payable	10.31	2.48	8.05	7.98	0.25	1.34
Current Unearned Revenue	2.71	2.21	6.02	1.2	1.45	0.86
Other Current Liabilities	4	3.81	2.64	2.47	1.92	2.2
Total Current Liabilities	42.54	51.57	47.48	68.12	81.77	54.18
Long-Term Debt	-	-	-	46.43	50.3	101.67
Long-Term Leases	8.77	-	-	1.01	2.85	6.62
Long-Term Unearned Revenue	41.24	45.51	51.8	35.28	6.8	8.44
Long-Term Deferred Tax Liabilities	0.28	0.3	0.29	0.26	0.62	-
Total Liabilities	92.83	97.38	99.57	151.11	142.34	170.92

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	67.63	67.05	66.52	66.06	66.06	66.06
Additional Paid-In Capital	501.42	484.69	463.95	441.66	436.19	436.19
Retained Earnings	296.59	252.95	179.53	126.96	99.29	70.01
Treasury Stock	-2.87	-7.89	-11.51	-	-	-
Comprehensive Income & Other	1.14	1.26	1.18	1.18	1.04	-
Total Common Equity	863.92	798.06	699.66	635.86	602.58	572.26
Minority Interest	-	-	-	-	-	3.61
Shareholders' Equity	863.92	798.06	699.66	635.86	602.58	575.87
Total Liabilities & Equity	956.76	895.44	799.23	786.97	744.92	746.78

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	8.77	-	1.01	53.13	81.65	110.7
Net Cash (Debt)	315.03	305.83	248.77	166.36	110.37	275.22
Net Cash Growth	23.46%	22.94%	49.53%	50.73%	-59.90%	61.87%
Net Cash Per Share	4.66	4.57	3.79	2.52	1.66	4.86
Filing Date Shares Outstanding	67.76	66.75	66.17	66.06	66.06	66.06
Total Common Shares Outstanding	67.76	66.75	66.17	66.06	66.06	66.06
Working Capital	365.67	323.63	264.93	201.59	156.48	362.96
Book Value Per Share	12.75	11.96	10.57	9.63	9.12	8.66
Tangible Book Value	801.22	729.96	636.61	565.85	551.27	517.6
Tangible Book Value Per Share	11.82	10.94	9.62	8.57	8.34	7.83
Buildings	-	300.03	293.55	289.32	277.02	-
Machinery	-	75.06	77.5	73.35	68.14	43.18
Construction In Progress	-	-	-	0.05	0.02	201.95

Data Source: S&P Global Market Intelligence Last updated: Oct 21, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error